Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Joop D Lefrandt"'
Publikováno v:
Endocrine Connections, Vol 10, Iss 1, Pp R43-R51 (2021)
Thyroid hormone stimulates cardiac inotropy and chronotropy via direct genomic and non-genomic mechanisms. Hyperthyroidism magnifies these effects, resulting in an increase in heart rate, ejection fraction and blood volume. Hyp erthyroidism also affe
Externí odkaz:
https://doaj.org/article/333e4dcf08824a81a1d0d2ced19a2d90
Autor:
Ingrid E Fakkert, Eveline van der Veer, Elske Marije Abma, Joop D Lefrandt, Bruce H R Wolffenbuttel, Jan C Oosterwijk, Riemer H J A Slart, Iris G Westrik, Geertruida H de Bock, Marian J E Mourits
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169673 (2017)
Risk-reducing salpingo-oophorectomy (RRSO) reduces ovarian cancer risk in BRCA1/2 mutation carriers. Premenopausal RRSO is hypothesized to increase fracture risk more than natural menopause. Elevated bone turnover markers (BTMs) might predict fractur
Externí odkaz:
https://doaj.org/article/3bb1fdbe4eda433abb8942ac8c325af2
Autor:
John H Meertens, Hans L Nienhuis, Joop D Lefrandt, Casper G Schalkwijk, Kristiina Nyyssönen, Jack J M Ligtenberg, Andries J Smit, Jan G Zijlstra, D J Mulder
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160893 (2016)
Advanced glycation end products (AGEs) have been implicated in multiple organ failure, predominantly via their cellular receptor (RAGE) in preclinical studies. Little is known about the time course and prognostic relevance of AGEs in critically ill h
Externí odkaz:
https://doaj.org/article/4cf5f2efc5ae4bedb3eab60ff265d8b3
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65490 (2013)
IntroductionDespite tight glycemic control, pregnancy complication rate in type 1 diabetes patients is higher than in normal pregnancy. Other etiological factors may be responsible for the development of adverse pregnancy outcome. Acceptance of the s
Externí odkaz:
https://doaj.org/article/66b081e1aec74d068c6f60845ace6e6c
Autor:
Martijn A M den Dekker, Marjan Zwiers, Edwin R van den Heuvel, Lisanne C de Vos, Andries J Smit, Clark J Zeebregts, Matthijs Oudkerk, Rozemarijn Vliegenthart, Joop D Lefrandt, Douwe J Mulder
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83084 (2013)
INTRODUCTION: Advanced glycation endproducts (AGEs) may be involved in the development of atherosclerosis, beyond diabetes and renal disease. Skin autofluorescence (AF) is a non-invasive marker for AGEs. We examined whether skin AF is increased in (s
Externí odkaz:
https://doaj.org/article/216ec3c1a0ce4d6a9520039b75750c6d
Autor:
Gabriela G.F. van der Schoot, Harm L. Ormel, Nico-Derk L. Westerink, Anne M. May, Sjoerd G. Elias, Yoran M. Hummel, Joop D. Lefrandt, Peter van der Meer, Joost P. van Melle, Boelo J. Poppema, Joyce M.A. Stel, Annette W.G. van der Velden, Aline H. Vrieling, Johan B. Wempe, Marcel G. ten Wolde, Marcel Nijland, Elisabeth G.E. de Vries, Jourik A. Gietema, Annemiek M.E. Walenkamp
Publikováno v:
JACC: CardioOncology. 4:491-503
Autor:
Mirthe H. Links, Joop D. Lefrandt, Ton Lisman, Trynke van der Boom, Michaël V. Lukens, Karina Meijer, Thera P. Links, Wouter T. Zandee
Publikováno v:
Thyroid, 33(2), 203-213. MARY ANN LIEBERT, INC
BACKGROUND: During treatment for differentiated thyroid carcinoma (DTC) patients go from euthyroidism to severe hypothyroidism to subclinical hyperthyroidism induced by thyroid hormone suppression therapy (THST). Severe hypothyroidism may induce a te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8cbcc78ce867640e64d20472ecfd749
https://research.rug.nl/en/publications/dbfa9959-9eaa-42f5-b2c8-29d8699517dc
https://research.rug.nl/en/publications/dbfa9959-9eaa-42f5-b2c8-29d8699517dc
Autor:
Sjoukje Lubberts, Harmke J. Groot, Ronald de Wit, Sasja Mulder, Johannes A. Witjes, J. Martijn Kerst, Gerard Groenewegen, Joop D. Lefrandt, Flora E. van Leeuwen, Janine Nuver, Michael Schaapveld, Jourik A. Gietema
Publikováno v:
Journal of Clinical Oncology, 41, 19, pp. 3512-3522
PURPOSE Testicular cancer (TC) treatment is clearly associated with cardiovascular morbidity and mortality. To enable development of preventive strategies for cardiovascular disease (CVD), we assessed cardiometabolic risk factors and quality of life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bce1af2304f7ae8686760e46080c292
https://repository.ubn.ru.nl/handle/2066/294345
https://repository.ubn.ru.nl/handle/2066/294345
Autor:
Geertruida H. de Bock, Mathilde Jalving, Anne M. Hendriks, Panagiotis Giannopoulos, Wim Timens, Adrienne H. Brouwers, Harry J.M. Groen, Joop D. Lefrandt
Publikováno v:
Journal of Cancer
Journal of Cancer, 12(2), 562-570. IVYSPRING INT PUBL
Journal of Cancer, 12(2), 562-570. IVYSPRING INT PUBL
Background: Reprogrammed glucose metabolism is a hallmark of cancer making it an attractive therapeutic target, especially in cancers with high glucose uptake such as non-small cell lung cancer (NSCLC). Tools to select patients with high glucose upta
Autor:
Annemiek, van Ommen-Nijhof, Judy N, Jacobse, Lars C, Steggink, Joop D, Lefrandt, Jourik A, Gietema, Flora E, van Leeuwen, Michael, Schaapveld, Gabe S, Sonke
Publikováno v:
Breast cancer research and treatment. 196(3)
Aromatase inhibitors (AIs) are an important component of the adjuvant treatment of hormone receptor positive breast cancer (BC) but concerns regarding their cardiovascular safety remain. In this cross-sectional study nested in a breast cancer cohort,